Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achie...

Full description

Bibliographic Details
Main Authors: Rong Rong, Bing Li, Rebecca M Lynch, Richard E Haaland, Megan K Murphy, Joseph Mulenga, Susan A Allen, Abraham Pinter, George M Shaw, Eric Hunter, James E Robinson, S Gnanakaran, Cynthia A Derdeyn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-09-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC2741593?pdf=render